Your browser doesn't support javascript.
loading
Mood in Parkinson's disease: From early- to late-stage disease.
Santos-García, Diego; De Deus, Fonticoba T; Cores, Bartolome C; Valdés, Aymerich L; Suárez, Castro E; Aneiros, Ángel; Jesús, Silvia; Aguilar, Miquel; Pastor, Pau; Planellas, Lluís; Cosgaya, Marina; García, Caldente J; Caballol, Nuria; Legarda, Inés; Hernández, Vara J; Cabo, Iria; López, Manzanares L; González, Aramburu I; Ávila, Rivera M A; José, Catalán M; Nogueira, Víctor; Puente, Víctor; García, Moreno J M; Borrué, Carmen; Solano, Vila B; Álvarez, Sauco M; Vela, Lydia; Escalante, Sonia; Cubo, Esther; Carrillo, Padilla F; Martínez, Castrillo J C; Sánchez, Alonso P; Alonso, Losada M G; López, Ariztegui N; Gastón, Itziar; Kulisevsky, Jaime; Blázquez, Estrada M; Seijo, Manuel; Rúiz, Martínez J; Valero, Caridad; Kurtis, Mónica; de Fábregues-Boixar, Oriol; González, Ardura J; Prieto, Jurczynska C; López, Díaz L; McAfee, Darrian; Mir, Pablo.
Affiliation
  • Santos-García D; Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
  • De Deus FT; Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.
  • Cores BC; Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
  • Valdés AL; Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
  • Suárez CE; Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.
  • Aneiros Á; Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain.
  • Jesús S; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Aguilar M; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Pastor P; Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Planellas L; Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Cosgaya M; Hospital Clínic de Barcelona, Barcelona, Spain.
  • García CJ; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Caballol N; Centro Neurológico Oms 42, Palma de Mallorca, Spain.
  • Legarda I; Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain.
  • Hernández VJ; Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Cabo I; Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • López ML; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • González AI; Hospital Universitario La Princesa, Madrid, Spain.
  • Ávila RMA; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • José CM; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Nogueira V; Consorci Sanitari Integral, Hospital General de L´Hospitalet, Barcelona, Spain.
  • Puente V; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • García MJM; Hospital Da Costa, Burela, Lugo, Spain.
  • Borrué C; Hospital del Mar, Barcelona, Spain.
  • Solano VB; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Álvarez SM; Hospital Infanta Sofía, Madrid, Spain.
  • Vela L; Institut d'Assistència Sanitària (IAS) - Institut Català de la Salut, Girona, Spain.
  • Escalante S; Hospital General Universitario de Elche, Elche, Spain.
  • Cubo E; Fundación Hospital de Alcorcón, Madrid, Spain.
  • Carrillo PF; Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.
  • Martínez CJC; Complejo Asistencial Universitario de Burgos, Burgos, Spain.
  • Sánchez AP; Hospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain.
  • Alonso LMG; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • López AN; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Gastón I; Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
  • Kulisevsky J; Complejo Hospitalario de Toledo, Toledo, Spain.
  • Blázquez EM; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Seijo M; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Rúiz MJ; Hospital de Sant Pau, Barcelona, Spain.
  • Valero C; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Kurtis M; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • de Fábregues-Boixar O; Hospital Universitario Donostia, San Sebastián, Spain.
  • González AJ; Hospital Arnau de Vilanova, Valencia, Spain.
  • Prieto JC; Hospital Ruber Internacional, Madrid, Spain.
  • López DL; Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • McAfee D; Hospital Universitario Lucus Augusti (HULA), Lugo, Spain.
  • Mir P; Hospital Rey Juan Carlos, Madrid, Spain.
Int J Geriatr Psychiatry ; 36(5): 627-646, 2021 05.
Article in En | MEDLINE | ID: mdl-33169885
ABSTRACT

BACKGROUND:

Although depression is known to be frequent in Parkinson's disease (PD), it is unclear how mood can change and/or impact on patient's quality of life (QoL) over time. Our aim was to analyze the frequency of depression, mood related factors and the contribution of mood to a patient's QoL perception in regard to disease duration.

METHODS:

PD patients recruited from the COPPADIS cohort from January 2016 to November 2017 were included in this cross-sectional study. Three groups were defined <5 years (Group A); from 5 to <10 years (Group B); ≥10 years (Group C). Analysis with well-planned linear regression models was conducted to determine how different factors contribute to mood (Beck Depression Inventory-II [BDI-II] as dependent variable), to health-related QoL (39-item Parkinson's Disease Questionnaire [PDQ-39SI] as dependent variable) and to global QoL (European Health Interview Survey - Quality of Life Eight-Item Index [EUROHIS-QOL8] as dependent variable).

RESULTS:

Six hundred and sixty-three PD patients (62.6 ± 8.9 years old, 59.6% males) were included Group A, 50.1% (n = 332); Group B, 33.3% (n = 221) and Group C, 16.6% (n = 110). There were no differences between the three groups in terms of the frequency of depressive symptoms nor the frequency of depression type (major vs. minor vs. subthreshold) (p = 0.729). However, the unique percent variance of PDQ-39SI and EUROHIS-QOL8 explained by BDI-II total score was 2 (23.7%) and threefold (26.9%), respectively, in Group C compared to the other two groups. EUROHIS-QOL8 total score provided the highest unique contribution to mood (16.8%).

CONCLUSIONS:

Although depression-type frequency does not appear to change over time in PD; the contribution of mood on QoL perception is greater in patients with longer disease duration.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male Language: En Journal: Int J Geriatr Psychiatry Journal subject: GERIATRIA / PSIQUIATRIA Year: 2021 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male Language: En Journal: Int J Geriatr Psychiatry Journal subject: GERIATRIA / PSIQUIATRIA Year: 2021 Document type: Article Affiliation country: España